
    
      OBJECTIVES:

        -  Evaluate the overall survival of patients with newly diagnosed glioblastoma multiforme
           treated with boron neutron capture therapy, radiotherapy, and concurrent and adjuvant
           temozolomide.

        -  Evaluate tumor response in patients treated with this regimen.

        -  Evaluate the adverse effects of this regimen in these patients.

      OUTLINE: This is a multicenter study.

      Patients undergo boron neutron capture therapy followed by radiotherapy and concurrent and
      adjuvant oral temozolomide.
    
  